Catalyst Wire Dossier Catalyst Wire Dossier

Dorzolamide and Timolol Ophthalmic Solution

Dorzolamide hydrochloride and timolol maleate ophthalmic solution · Leading Pharma, LLC
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Dorzolamide and Timolol Ophthalmic Solution, covering 2019-06-13 to 2019-06-13. Get the full timeline:

Most recent: FDA Approved: DORZOLAMIDE AND TIMOLOL — Original Application (Leading Pharma, LLC)

See pricing